Press release
27.06.2023 To the attention of interested persons Withdrawal of application for the marketing authorisation of Lagevrio (molnupiravir) download document …
Press release
23.06.2023 To the attention of interested persons Refusal of the marketing authorisation for Albrioza (sodium phenylbutyrate / ursodoxicoltaurine) download document […]
Important notification
22.06.2023 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that Commission Implementing Regulation […]
Press release
26.05.2023 To the attention of interested persons EMA recommends revocation of authorisation for sickle cell disease medicine Adakveo download document […]
Important notification
19.05.2023 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be advised that on 12 May […]
Press release
12.05.2023 To the attention of interested persons Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and […]
Press release
12.05.2023 To the attention of interested persons Review of hydroxyprogesterone started. download document …
Important notification
11.05.2023 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that on 10 May […]
Important notification
20.04.2023 To the attention of interested persons The NAMMDR would like to inform you about the 10th Romanian Pharmacovigilance Workshop […]
Important notification
31.03.2023 To the attention of economic operators who request the approval of the activity of installation and/or maintenance of medical […]